Palmetto GBA released a final local coverage determination that covers tests from Castle Biosciences and SkylineDx.
With paleogenetics and archaeological data, investigators profiled individuals killed by the Mount Vesuvius eruption, generating a genome sequence for one of the ancient Pompeiians.
By profiling the gut microbiome and blood immune cells, researchers found features linked to good outcomes and lower graft-versus-host disease rates.
CorePath will develop and offer UK-based Cizzle's test in the US, with royalty agreements on all product and services offerings related to the test.
The SARS-CoV-2/flu assay is the second test available on the high-throughput BD Cor PX/MX system.
The panel, which tests for flu, respiratory syncytial virus, and SARS-CoV-2, expands the company's menu for the molecular Q-POC platform.
Researchers developed a "mitochondrial orphan protein multi-omics" (MITOMICS) app by profiling proteins, lipids, and metabolites in cells lacking individual mitochondrial proteins.
StageZero's Aristotle test uses mRNA technology to identify the molecular signatures of multiple cancer types.
Funding for the tests will be provided as part of a previously announced $205.2 million contract with the US Defense Logistics Agency.
The EBV and BK virus tests, the first quantitative assays developed for the Panther Fusion system, expand Hologic’s transplant pathogen monitoring menu.